Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019F, a FasTCAR-enabled CD19-directed autologous CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult B cell acute lymphoblastic leukemia (B-ALL), as well as in preclinical stage for the treatment of relapsed or refractory (r/r) B cell non-Hodgkin's lymphoma (B-NHL); and GC027, a TruUCAR-enabled CD7-directed allogeneic CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult T cell acute lymphoblastic leukemia. The company's product candidates also comprise GC007g, a donor-derived CD19-directed allogeneic CAR-T cell therapy that is in Phase 1/2 registrational trial clinical trial for the treatment of r/r B-ALL; and GC502, a TruUCAR-enabled dual CD19- and CD7 -directed, off-the-shelf allogeneic CAR-T product candidate, which is in Phase I trial for the treatment of B-cell malignancies. In addition, it has a portfolio of earlier stage product candidates targeting various cancer indications, such as ovarian cancer, breast cancer, peripheral T cell lymphoma, a subtype of NHL, and T cell lymphoblastic leukemia. The company was founded in 2017 and is headquartered in Suzhou, China.

Filer	Shares	Latest Filing Date	Previously owned	Change	Share-Type	Market Value
Orbimed Advisors Llc	7.88M	2021-05-17	0	7.88M	Shares	121.43M
Wellington Management Group...	2.65M	2021-05-17	0	2.65M	Shares	40.74M
Great Point Partners Llc	2.27M	2023-08-14	3.15M	-885.15K	Shares	8.64M
Logos Global Management Lp	1.80M	2023-08-14	0	1.80M	Shares	6.86M
Vivo Capital, Llc	1.52M	2021-05-17	0	1.52M	Shares	23.45M
Viking Global Investors Lp	1.35M	2021-05-17	0	1.35M	Shares	20.71M
Federated Hermes, Inc.	1.19M	2021-05-13	0	1.19M	Shares	18.34M
Capital International Inves...	1.12M	2021-05-14	0	1.12M	Shares	17.29M
Blackrock Inc.	954.46K	2021-05-07	0	954.46K	Shares	14.70M
Morgan Stanley	921.03K	2021-05-17	0	921.03K	Shares	14.18M
Capital International, Inc....	882.77K	2021-05-14	0	882.77K	Shares	13.60M
Deerfield Management Compan...	400K	2021-05-17	0	400K	Shares	6.16M
Temasek Holdings (Private) Ltd	263.16K	2021-05-17	0	263.16K	Shares	4.05M
Sphera Funds Management Ltd.	212.60K	2021-05-17	0	212.60K	Shares	3.27M
State Of Wisconsin Investme...	162.69K	2021-05-17	0	162.69K	Shares	2.50M
Fmr Llc	153.89K	2021-05-14	0	153.89K	Shares	2.37M
Capital International Sarl	133.28K	2021-05-14	0	133.28K	Shares	2.05M
Boyu Capital Investment Man...	127.61K	2021-05-17	0	127.61K	Shares	1.97M
Cormorant Asset Management, Lp	125K	2021-05-17	0	125K	Shares	1.93M
Marshall Wace, Llp	100.43K	2021-05-17	0	100.43K	Shares	1.55M
Indus Capital Partners, Llc	86.31K	2021-05-14	0	86.31K	Shares	1.33M
Marshall Wace North America...	83.56K	2021-08-27	0	83.56K	Shares	1.29M
Zimmer Partners, Lp	70K	2021-05-17	0	70K	Shares	1.08M
Victory Capital Management Inc	66.85K	2021-05-04	0	66.85K	Shares	1.03M
Millennium Management Llc	59.43K	2021-05-17	0	59.43K	Shares	915K
Schonfeld Strategic Advisor...	53.31K	2021-05-17	0	53.31K	Shares	822K
New Silk Road Investment Pt...	50K	2021-05-13	0	50K	Shares	770K
Alyeska Investment Group, L.P.	50K	2021-05-17	0	50K	Shares	770K
Nomura Holdings Inc	43.25K	2021-05-17	0	43.25K	Shares	636K
Citadel Advisors Llc	38.70K	2021-05-21	0	38.70K	Shares	596K
Norges Bank	20K	2022-05-09	0	20K	Shares	308K
Alphacentric Advisors Llc	19K	2022-03-09	0	19K	Shares	293K
Davidson Kempner Capital Ma...	17.50K	2021-05-17	0	17.50K	Shares	265K
Two Sigma Investments, Lp	13.17K	2021-05-17	0	13.17K	Shares	203K
Wells Fargo & Company/Mn	7.71K	2021-05-13	0	7.71K	Shares	119K
Pinz Capital Management, Lp	2.91K	2021-05-17	0	2.91K	Shares	45K
Citigroup Inc	1K	2021-05-13	0	1K	Shares	15K
Td Capital Management Llc	333	2021-05-10	0	333	Shares	5K
Concourse Financial Group S...	0	2021-05-13	0	0	Shares	0

NASDAQ:GRCL

Gracell Biotechnologies Inc.

Last Close

10.24

21/02 21:00

Market Cap

965.02M

Beta: −1.83

Volume Today

6.37M

Avg: 131.30K

PE Ratio

−12.25

PFCF: -

Institutional trades

Institutional Ownership

Current holdings institutionals

Please Sign In To Use The Chat